GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
DCM Shriram Ltd

DCM Shriram Q2 FY27 Consolidated Revenue Up 22% to ₹3,977 Crore

RESULTS ▼ Concern Flagged MEDIUM RISK
📅 Filed on BSE: 26 Oct 2026, 06:58 PM IST  ·  BSE ID: 40596a77-7511-4abe-8559-6b516f710b5a
View Original BSE Filing (PDF)
💡
In Simple Terms
DCM Shriram's latest financial results show higher revenue but lower profits for the second quarter of the current fiscal year.
🤖 AI Summary
  • DCM Shriram's consolidated Net Revenue for Q2 FY27 increased 22% to ₹3,977 Crore from ₹3,272 Crore.
  • Consolidated PBDIT for Q2 FY27 declined 22% to ₹420 Crore compared to ₹541 Crore in Q2 FY26.
  • Consolidated PAT for Q2 FY27 decreased 33% to ₹219 Crore from ₹327 Crore in Q2 FY26.
  • The Board announced an interim dividend of 200%, amounting to Rs. 4 per share.
  • Chemicals & Vinyl segment revenue grew 42% to ₹1,577 Crore in Q2 FY27, while its PBIT declined 33% to ₹134 Crore.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Consolidated Net Revenue Q2 FY27
₹3,977 Crore
22%
Consolidated PBDIT Q2 FY27
₹420 Crore
-22%
Consolidated PAT Q2 FY27
₹219 Crore
-33%
Interim Dividend per share
Rs. 4
Chemicals & Vinyl Revenue Q2 FY27
₹1,577 Crore
42%
Chemicals & Vinyl PBIT Q2 FY27
₹134 Crore
-33%
🏢 How This Affects the Company
📈
Business Impact
The Chemicals & Vinyl segment achieved a 42% revenue increase in Q2 FY27, driven by higher ECU and caustic volumes and new product contributions. Fenesta Building Systems continued its volume-driven growth.
💰
Financial Impact
Consolidated Net Revenue increased by 22% in Q2 FY27, however, consolidated PBDIT decreased by 22% and PAT by 33%. Segment PBIT margins declined for Chemicals & Vinyl and Shriram Farm Solutions.
⚙️
Operational Impact
Key milestones were reached with the commissioning of the Aluminium Chloride plant, partial commissioning of the Calcium Chloride plant, and a 68 MW (peak) renewable power project. Fenesta commissioned phase one of its Aluminium Extrusion Plant.
⚠️
Risk Impact
Bioseed business faced significant performance challenges in India and the Philippines due to El-Nino conditions. Sugar and Ethanol businesses are navigating impacts from government tenders restricting certain sugarcane-based feedstocks.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required by shareholders based on this investor presentation filing.
👤
Who Is Affected
All shareholders are affected by the company's financial performance, including the 22% increase in consolidated revenue and the 33% decrease in consolidated PAT for Q2 FY27. Shareholders will receive an interim dividend of Rs. 4 per share.
🔍
Management Signal
Management is signaling continued strategic investments in capacity expansion and integration, alongside active navigation of volatile global and domestic market conditions across its diverse business segments.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Q3 FY27 financial results — assess PBDIT and PAT trends for improvement
Updates on new project commissioning and capacity utilization in Chemicals segment
Further clarity on government policies impacting Sugar & Ethanol businesses
MEDIUM RISK Profitability declined significantly in Q2 FY27 despite revenue growth, indicating margin pressures and challenges in some segments.
💡 Investor Takeaway
DCM Shriram reported Q2 FY27 consolidated Net Revenue of ₹3,977 Crore, a 22% increase, but PBDIT decreased 22% to ₹420 Crore and PAT fell 33% to ₹219 Crore. The Chemicals & Vinyl segment's revenue growth was offset by a PBIT decline of 33%. An interim dividend of Rs. 4 per share was approved.
⚖️ Strengths & Concerns

✅ Positives

  • Q2 FY27 Consolidated Net Revenue increased 22% to ₹3,977 Crore, demonstrating growth in topline performance.
  • Chemicals & Vinyl segment revenue grew 42% to ₹1,577 Crore in Q2 FY27, with Chemicals sub-segment up 47%.

⚠️ Concerns

  • Q2 FY27 Consolidated PBDIT declined 22% to ₹420 Crore, with PAT decreasing 33% to ₹219 Crore.
  • Bioseed segment reported a PBIT loss of ₹(43) Crore in Q2 FY27, down from a loss of ₹(9) Crore in Q2 FY26.
📅 Company Track Record
DCM Shriram's Q2 FY27 consolidated revenue grew 22% to ₹3,977 crore, following a 9% growth in Q1 FY27 consolidated Net Revenue to ₹3,564 crore. The company approved ₹325 Crores capex for expansion and declared a ₹4 interim dividend, consistent with its H1 FY27 standalone profit of ₹855.78 Crores.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What was DCM Shriram's consolidated Net Revenue for Q2 FY27?
DCM Shriram's consolidated Net Revenue for Q2 FY27 was ₹3,977 Crore, representing a 22% increase from ₹3,272 Crore in Q2 FY26.
What was DCM Shriram's consolidated PBDIT for Q2 FY27?
DCM Shriram's consolidated PBDIT for Q2 FY27 was ₹420 Crore, a decrease of 22% compared to ₹541 Crore in Q2 FY26.
What interim dividend did DCM Shriram declare for FY27?
DCM Shriram declared an interim dividend of 200%, amounting to Rs. 4 per share, totaling Rs. 62.38 crores.
How did the Chemicals & Vinyl segment perform in Q2 FY27?
The Chemicals & Vinyl segment's revenue increased by 42% to ₹1,577 Crore in Q2 FY27, while its PBIT declined by 33% to ₹134 Crore.
What was DCM Shriram's consolidated PAT for Q2 FY27?
DCM Shriram's consolidated PAT for Q2 FY27 was ₹219 Crore, a 33% decrease from ₹327 Crore in Q2 FY26.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.